PVMIX | VMVAX | PVMIX / VMVAX | |
Total Expense Ratio | 0.69 | 0.07 | 986% |
Annual Report Gross Expense Ratio | 0.75 | 0.07 | 1,071% |
Fund Existence | 22 years | 14 years | - |
Gain YTD | 4.185 | 6.339 | 66% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.3B | 32.5B | 7% |
Annual Yield % from dividends | 1.29 | 2.17 | 59% |
Returns for 1 year | -13.67 | 1.20 | -1,136% |
Returns for 3 years | 7.34 | 36.10 | 20% |
Returns for 5 years | 27.48 | 63.10 | 44% |
Returns for 10 years | 27.10 | 99.51 | 27% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BSGPX | 13.90 | 0.12 | +0.87% |
Baillie Gifford Developed EAFE All Cap I | |||
ARYCX | 25.60 | 0.19 | +0.75% |
American Century Real Estate C | |||
VSNGX | 66.80 | 0.17 | +0.26% |
JPMorgan Mid Cap Equity I | |||
FGFCX | 41.59 | N/A | N/A |
Federated Hermes International Leaders C | |||
EMWLX | 19.98 | N/A | N/A |
Lord Abbett Emerging Markets Equity R6 |